Dépôt numérique

CLN3, at the crossroads of endocytic trafficking

Cotman, Susan L et Lefrancois, Stephane ORCID logoORCID: https://orcid.org/0000-0002-3312-9594 (2021). CLN3, at the crossroads of endocytic trafficking Neuroscience Letters , vol. 762 , nº 136117. pp. 1-12. DOI: 10.1016/j.neulet.2021.136117.

Ce document n'est pas hébergé sur EspaceINRS.


The CLN3 gene was identified over two decades ago, but the primary function of the CLN3 protein remains unknown. Recessive inheritance of loss of function mutations in CLN3 are responsible for juvenile neuronal ceroid lipofuscinosis (Batten disease, or CLN3 disease), a fatal childhood onset neurodegenerative disease causing vision loss, seizures, progressive dementia, motor function loss and premature death. CLN3 is a multipass transmembrane protein that primarily localizes to endosomes and lysosomes. Defects in endocytosis, autophagy, and lysosomal function are common findings in CLN3-deficiency model systems. However, the molecular mechanisms underlying these defects have not yet been fully elucidated. In this mini-review, we will summarize the current understanding of the CLN3 protein interaction network and discuss how this knowledge is starting to delineate the molecular pathogenesis of CLN3 disease. Accumulating evidence strongly points towards CLN3 playing a role in regulation of the cytoskeleton and cytoskeletal associated proteins to tether cellular membranes, regulation of membrane complexes such as channels/transporters, and modulating the function of small GTPases to effectively mediate vesicular movement and membrane dynamics.

Type de document: Article
Mots-clés libres: Actin; Autophagy; CLN3; Cytoskeleton; Endocytosis; Intracellular Trafficking; Ion Channels
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 22 juin 2022 19:23
Dernière modification: 22 juin 2022 19:23
URI: https://espace.inrs.ca/id/eprint/12317

Gestion Actions (Identification requise)

Modifier la notice Modifier la notice